CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 10 enrolled
Drug / intervention
Lidocaine +3 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03666663
NCT03666663Phase 4Completed
CompareCT.gov

UCSF Sphenopalatine Ganglion Block Study- a Randomized Double Blind Placebo Controlled Trial to Compare Nasal Anesthetics for Migraine Prevention in Adults.

University of California, San Francisco·interventional·Posted Sep 12, 2018·Updated Oct 11, 2021

In Brief

A Phase 4 clinical trial evaluating Lidocaine, Bupivacaine, and 2 other interventions for Migraine. Completed, enrolled 10 participants across 1 site.

Detailed Summary

RCT of Sphenopalatine Ganglion (SPG) Blocks using anesthetics vs. placebo for migraine.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsMigraine
CountriesUnited States
Collaborators--

Timeline

Phase 4CompletedFinished
20192020202120222023202420252026
First PostedSep 12, 2018
Enrollment StartFeb 1, 2019
Primary CompletionJul 8, 2021
TodayJul 2, 2026
Enrollment to primary: 2.4 yearsPosted 7.8 years ago

Interventions

Lidocainedrug

Nasal application using the Sphenocath device- cleared by FDA

Bupivacainedrug

Nasal application using the Sphenocath device- cleared by FDA

Ropivacainedrug

Nasal application using the Sphenocath device- cleared by FDA

Placebodrug

Placebo Saline using the Sphenocath device- cleared by FDA